A comprehensive view of Laboratorios Farmacéuticos Rovi S.A.. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.
Laboratorios Farmacéuticos Rovi in Spain gains FDA approval for producing Moderna's COVID-19 Spikevax vaccine at its Granada plant for US market; CEO Juan López-Belmonte sees future CDMO services growth and expects higher demand for Spikevax
Published:
February 28, 2024
by FiercePharma
|
Ask us about our Health Care Sector market view